GAM Holding AG - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAM Holding AG ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$544,000
-28.0%
10,527
-51.3%
0.02%
-45.7%
Q3 2020$756,000
-34.5%
21,6000.0%0.05%
-36.1%
Q2 2020$1,155,000
+50.8%
21,6000.0%0.07%
+38.5%
Q1 2020$766,000
-25.7%
21,6000.0%0.05%
+6.1%
Q4 2019$1,031,000
+47.3%
21,6000.0%0.05%
+58.1%
Q3 2019$700,000
-35.0%
21,6000.0%0.03%
-26.2%
Q2 2019$1,077,000
-26.1%
21,6000.0%0.04%
-31.1%
Q1 2019$1,457,000
+46.3%
21,6000.0%0.06%
+22.0%
Q4 2018$996,000
-46.6%
21,600
-10.7%
0.05%
-26.5%
Q3 2018$1,866,000
-8.4%
24,2000.0%0.07%
-4.2%
Q2 2018$2,038,000
+3.0%
24,2000.0%0.07%
+1.4%
Q1 2018$1,979,000
+43.0%
24,2000.0%0.07%
+66.7%
Q4 2017$1,384,000
+168.7%
24,200
+142.0%
0.04%
+425.0%
Q2 2017$515,000
+25.9%
10,000
+42.9%
0.01%
+33.3%
Q1 2017$409,000
+40.1%
7,0000.0%0.01%
+20.0%
Q4 2016$292,000
-21.1%
7,0000.0%0.01%
-28.6%
Q3 2016$370,000
-77.6%
7,000
-82.2%
0.01%
-73.1%
Q2 2016$1,651,000
+13.9%
39,400
+10.4%
0.03%
+8.3%
Q1 2016$1,449,000
-51.2%
35,700
-21.9%
0.02%
-47.8%
Q4 2015$2,967,000
+185.8%
45,700
+210.9%
0.05%
+155.6%
Q3 2015$1,038,000
+146.0%
14,700
+286.8%
0.02%
+200.0%
Q2 2015$422,0003,8000.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders